Clinical trial
Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
NCT02574403 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
- Lead sponsor
- Nantes University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- December 3, 2019
- Enrollment
- 58 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.